Please Wait
Applying Filters...
menu
    • menu
    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Lansoloc

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amarin Marks Milestone for VASCEPA®/VAZKEPA® - REDUCE-IT Analysis
    Amarin Marks Milestone for VASCEPA®/VAZKEPA® - REDUCE-IT Analysis

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033894/18362/en/Amarin-Marks-Key-Milestone-for-VASCEPA-VAZKEPA-Icosapent-Ethyl-Publication-of-Post-Hoc-Analysis-of-REDUCE-IT-in-Journal-of-the-American-Heart-Association-Reports-Benefit-on-Top-of-.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    Amarin Receives National Reimbursement for VAZKEPA® in Austria
    Amarin Receives National Reimbursement for VAZKEPA® in Austria

    25 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/25/3031955/18362/en/Amarin-Receives-National-Reimbursement-for-VAZKEPA-in-Austria.html

    GLOBENEWSWIRE
    25 Feb 2025
    Share Share
    Amarin to Report Q4 and Full Year 2024 Results on March 12, 2025
    Amarin to Report Q4 and Full Year 2024 Results on March 12, 2025

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/19/3028763/18362/en/Amarin-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Host-Conference-Call-on-March-12-2025.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Amarin Appoints Peter Fishman Chief Financial Officer
    Amarin Appoints Peter Fishman Chief Financial Officer

    13 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/13/2996829/18362/en/Amarin-Appoints-Peter-Fishman-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    13 Dec 2024
    Share Share
    REDUCE-IT Subanalysis on VASCEPA®/VAZKEPA® at AHA 2024
    REDUCE-IT Subanalysis on VASCEPA®/VAZKEPA® at AHA 2024

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978267/18362/en/Investigators-to-Present-New-REDUCE-IT-Subanalysis-of-VASCEPA-VAZKEPA-icosapent-ethyl-in-Patients-With-and-Without-Coronary-Artery-Disease-History-and-Mechanistic-Data-on-Eicosapen.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share
    Macleods`s Generics Lansoprazole Receives Approval in US
    Macleods`s Generics Lansoprazole Receives Approval in US

    04 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208671

    FDA
    04 Nov 2024
    Share Share